LAURA LOWRY: Open Payments
NPI 1841408390 · FULLERTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 32 payments from 8 companies in 2025. Trend: 2023 $511 · 2024 $696 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $244 |
| Amgen Inc. | 6 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
| ABIOMED | 1 | $25 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: VYNDAQEL, REPATHA, LEQVIO, EVKEEZA, FUROSCIX, LifeVest, JARDIANCE, ELIQUIS.
Industry payments across CA — which companies pay providers there.
